Striatal spatial heterogeneity, clustering, and white matter association of GFAP+ astrocytes in a mouse model of Huntington’s disease
暂无分享,去创建一个
Sarah R. Heilbronner | Nicole Zarate | Taylor G. Brown | Rocio Gomez-Pastor | Mackenzie Thayer | Damyan W. Hart | Jillian G. VanTreeck
[1] B. Khakh,et al. Neuronal and astrocytic contributions to Huntington's disease dissected with zinc finger protein transcriptional repressors. , 2023, Cell reports.
[2] D. Hu,et al. The neurons in mouse V1 show different degrees of spatial clustering , 2022, Brain Research Bulletin.
[3] J. Lucas,et al. CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease , 2022, Acta Neuropathologica Communications.
[4] T. V. Johnson,et al. Analyses of transplanted human retinal ganglion cell morphology and localization in murine organotypic retinal explant culture , 2022, STAR protocols.
[5] Luciano da F. Costa,et al. Maternal high-fat diet in mice induces cerebrovascular, microglial and long-term behavioural alterations in offspring , 2022, Communications Biology.
[6] OUP accepted manuscript , 2022, Brain.
[7] M. Qiu,et al. S100B is selectively expressed by gray matter protoplasmic astrocytes and myelinating oligodendrocytes in the developing CNS , 2021, Molecular Brain.
[8] M. Götz,et al. Molecular diversity of diencephalic astrocytes reveals adult astrogenesis regulated by Smad4 , 2021, The EMBO journal.
[9] J. Wityak,et al. Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates , 2021, Scientific Reports.
[10] G. Halliday,et al. Early white matter pathology in the fornix of the limbic system in Huntington disease , 2021, Acta Neuropathologica.
[11] S. Liddelow,et al. Neuroinflammatory astrocyte subtypes in the mouse brain , 2021, Nature Neuroscience.
[12] A. Benraiss,et al. Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease. , 2021, Cell reports.
[13] Kira E. Poskanzer,et al. Reactive astrocyte nomenclature, definitions, and future directions , 2021, Nature Neuroscience.
[14] B. Balleine,et al. The dorsomedial striatum: an optimal cellular environment for encoding and updating goal-directed learning , 2021, Current Opinion in Behavioral Sciences.
[15] B. Eggen,et al. Transcriptional heterogeneity between primary adult grey and white matter astrocytes underlie differences in modulation of in vitro myelination , 2020, Journal of Neuroinflammation.
[16] B. Khakh,et al. Context-Specific Striatal Astrocyte Molecular Responses Are Phenotypically Exploitable , 2020, Neuron.
[17] A. Reiner,et al. Progression of basal ganglia pathology in heterozygous Q175 knock‐in Huntington's disease mice , 2020, The Journal of comparative neurology.
[18] Derek K. Jones,et al. A Critical Review of White Matter Changes in Huntington’s Disease , 2020, Movement disorders : official journal of the Movement Disorder Society.
[19] C. Lohr,et al. Age-Dependent Heterogeneity of Murine Olfactory Bulb Astrocytes , 2020, Frontiers in Aging Neuroscience.
[20] J. Grutzendler,et al. Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo , 2020, Science Advances.
[21] R. Voituriez,et al. Cell clusters adopt a collective amoeboid mode of migration in confined nonadhesive environments , 2020, bioRxiv.
[22] F. Artigas,et al. M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington’s disease , 2020, bioRxiv.
[23] Chris P. Ponting,et al. Identification of region-specific astrocyte subtypes at single cell resolution , 2020, Nature Communications.
[24] Gurrein K. Madan,et al. Genome-wide In Vivo CNS Screening Identifies Genes that Modify CNS Neuronal Survival and mHTT Toxicity , 2020, Neuron.
[25] H. Yin,et al. Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival. , 2020, Cell reports.
[26] Stephen J. Eglen,et al. From random to regular: Variation in the patterning of retinal mosaics* , 2019, The Journal of comparative neurology.
[27] M. Tremblay,et al. Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain. , 2019, Journal of visualized experiments : JoVE.
[28] B. Khakh,et al. Astrocyte molecular signatures in Huntington’s disease , 2019, Science Translational Medicine.
[29] V. Menon,et al. Single-nucleus RNA-seq identifies Huntington disease astrocyte states , 2019, Acta Neuropathologica Communications.
[30] A. Citri,et al. Dorsal Striatal Circuits for Habits, Compulsions and Addictions , 2019, Front. Syst. Neurosci..
[31] B. Khakh,et al. The Emerging Nature of Astrocyte Diversity. , 2019, Annual review of neuroscience.
[32] M. Zoli,et al. Distribution and Relative Abundance of S100 Proteins in the Brain of the APP23 Alzheimer’s Disease Model Mice , 2019, Front. Neurosci..
[33] F. Michetti,et al. The S100B story: from biomarker to active factor in neural injury , 2018, Journal of neurochemistry.
[34] C. Cepeda,et al. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model , 2018, Human molecular genetics.
[35] A. Verkhratsky,et al. Neuroglia in Neurodegenerative Diseases , 2019, Advances in Experimental Medicine and Biology.
[36] H. Künzle,et al. Radial glial elements in the cerebral cortex of the lesser hedgehog tenrec , 2018, Brain Structure and Function.
[37] F. Cicchetti,et al. Mutant huntingtin protein expression and blood–spinal cord barrier dysfunction in huntington disease , 2017, Annals of neurology.
[38] B. Khakh,et al. Unravelling and Exploiting Astrocyte Dysfunction in Huntington’s Disease , 2017, Trends in Neurosciences.
[39] S. Giannetti,et al. The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93A Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes , 2017, Mediators of inflammation.
[40] S. Goto,et al. Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity , 2017, Brain sciences.
[41] Sarah R. Heilbronner,et al. Organization of the Anterior Limb of the Internal Capsule in the Rat , 2017, The Journal of Neuroscience.
[42] D. Thiele,et al. Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease , 2017, Nature Communications.
[43] Manoj Kumar,et al. INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.
[44] K. Nave,et al. Inducible targeting of CNS astrocytes in Aldh1l1-CreERT2 BAC transgenic mice , 2016, F1000Research.
[45] Tianyi Mao,et al. A comprehensive excitatory input map of the striatum reveals novel functional organization , 2016, eLife.
[46] Nicholas N. Foster,et al. The mouse cortico-striatal projectome , 2016, Nature Neuroscience.
[47] Jihwan Song,et al. Human-to-mouse prion-like propagation of mutant huntingtin protein , 2016, Acta Neuropathologica.
[48] R. Roos,et al. Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling , 2015, Front. Hum. Neurosci..
[49] E. Hol,et al. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. , 2015, Current opinion in cell biology.
[50] M. Hayden,et al. Huntington disease , 2015, Nature Reviews Disease Primers.
[51] P. Barker,et al. S100B protein activates a RAGE‐dependent autocrine loop in astrocytes: implications for its role in the propagation of reactive gliosis , 2014, Journal of neurochemistry.
[52] M. Nedergaard,et al. White matter astrocytes in health and disease , 2014, Neuroscience.
[53] Guy M McKhann,et al. Phenotypic Heterogeneity and Plasticity of Isocortical and Hippocampal Astrocytes in the Human Brain , 2014, The Journal of Neuroscience.
[54] Amin Derouiche,et al. Glutamine Synthetase as an Astrocytic Marker: Its Cell Type and Vesicle Localization , 2013, Front. Endocrinol..
[55] Manoj K. Gottipati,et al. Enhanced Ca2+-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model , 2013, Neurobiology of Disease.
[56] Rui Costa,et al. Premotor cortex is critical for goal-directed actions , 2013, Front. Comput. Neurosci..
[57] Milos Pekny,et al. Versatile and Simple Approach to Determine Astrocyte Territories in Mouse Neocortex and Hippocampus , 2013, PloS one.
[58] George V. Rebec,et al. Role of cerebral cortex in the neuropathology of Huntington's disease , 2013, Front. Neural Circuits.
[59] Mei Kwan,et al. Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175 , 2012, PloS one.
[60] Jack R Glaser,et al. Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease , 2012, PloS one.
[61] S. Itohara,et al. S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway , 2012, Brain : a journal of neurology.
[62] E. Hol,et al. GFAP Isoforms in Adult Mouse Brain with a Focus on Neurogenic Astrocytes and Reactive Astrogliosis in Mouse Models of Alzheimer Disease , 2012, PloS one.
[63] J. Rothstein,et al. Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice , 2011, Glia.
[64] R. Roos,et al. Huntington's disease: a clinical review , 2010, Orphanet journal of rare diseases.
[65] Ben A. Barres,et al. Regulation of synaptic connectivity by glia , 2010, Nature.
[66] M. Guillermier,et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects , 2010, Human molecular genetics.
[67] D. Oorschot,et al. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. , 2010, Brain : a journal of neurology.
[68] Peng Yu,et al. Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical “disconnection” , 2010, NeuroImage.
[69] Stefan Klöppel,et al. Functional compensation of motor function in pre-symptomatic Huntington's disease , 2009, Brain : a journal of neurology.
[70] Magdalena Götz,et al. Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain , 2008, Proceedings of the National Academy of Sciences.
[71] David S Tuch,et al. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.
[72] B. Harper. Huntington Disease , 2005, Journal of the Royal Society of Medicine.
[73] L. Eng,et al. Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000) , 2000, Neurochemical Research.
[74] K. Tohyama,et al. Nearest-neighbor distance of intermediate filaments in axons and schwann cells , 2004, Acta Neuropathologica.
[75] K. Fenger,et al. Molecular and behavioral analysis of the r6/1 huntington′s disease transgenic mouse , 2003, Neuroscience.
[76] N. D. Mar,et al. Differential Changes in Striatal Projection Neurons in R6/2 Transgenic Mice for Huntington's Disease , 2002, Neurobiology of Disease.
[77] G. Halliday,et al. Pyramidal Cell Loss in Motor Cortices in Huntington's Disease , 2002, Neurobiology of Disease.
[78] K. Lindenberg,et al. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. , 2002, Brain : a journal of neurology.
[79] D. Neary,et al. Behavior in Huntington's disease: dissociating cognition-based and mood-based changes. , 2002, The Journal of neuropsychiatry and clinical neurosciences.
[80] Mark Ellisman,et al. Protoplasmic Astrocytes in CA1 Stratum Radiatum Occupy Separate Anatomical Domains , 2002, The Journal of Neuroscience.
[81] R. Mrak,et al. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer’s disease , 2001, Neurobiology of Aging.
[82] A. Mahal,et al. Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice , 2001, Neurobiology of Disease.
[83] R. Reep,et al. Topographic organization of the striatal and thalamic connections of rat medial agranular cortex , 1999, Brain Research.
[84] Claire-Anne Gutekunst,et al. Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology , 1999, The Journal of Neuroscience.
[85] A. Araque,et al. Astrocyte-induced modulation of synaptic transmission. , 1999, Canadian journal of physiology and pharmacology.
[86] S. Thompson. Advances in experimental medicine and biology , 1996 .
[87] W. Griffin,et al. S100β protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaques , 1994 .
[88] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[89] J. Vonsattel,et al. Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.
[90] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[91] D. Selkoe,et al. Huntington's disease: Changes in striatal proteins reflect astrocytic gliosis , 1982, Brain Research.
[92] J. Vanderhaeghen,et al. An acidic protein isolated from fibrous astrocytes. , 1971, Brain research.